PARIBELLO, PASQUALE
 Distribuzione geografica
Continente #
EU - Europa 44.090
NA - Nord America 3.114
AS - Asia 2.087
SA - Sud America 512
AF - Africa 114
OC - Oceania 61
Continente sconosciuto - Info sul continente non disponibili 1
Totale 49.979
Nazione #
IT - Italia 43.052
US - Stati Uniti d'America 2.986
SG - Singapore 809
CN - Cina 610
BR - Brasile 421
SE - Svezia 282
DE - Germania 186
VN - Vietnam 180
GB - Regno Unito 122
HK - Hong Kong 87
FI - Finlandia 82
CA - Canada 81
KR - Corea 73
FR - Francia 63
AU - Australia 61
NL - Olanda 59
IN - India 56
JP - Giappone 54
MA - Marocco 37
AR - Argentina 36
AT - Austria 34
TR - Turchia 34
ZA - Sudafrica 34
MX - Messico 33
PL - Polonia 29
BD - Bangladesh 28
IE - Irlanda 25
CH - Svizzera 24
ID - Indonesia 21
ES - Italia 20
IR - Iran 16
RO - Romania 16
UA - Ucraina 16
IQ - Iraq 15
RU - Federazione Russa 15
EG - Egitto 14
PH - Filippine 13
LT - Lituania 12
CO - Colombia 11
EC - Ecuador 11
PK - Pakistan 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
KE - Kenya 9
PE - Perù 8
PT - Portogallo 8
BE - Belgio 7
IL - Israele 7
PY - Paraguay 7
UZ - Uzbekistan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
HU - Ungheria 6
NP - Nepal 6
CL - Cile 5
KG - Kirghizistan 5
KZ - Kazakistan 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
DZ - Algeria 4
LB - Libano 4
TH - Thailandia 4
TW - Taiwan 4
AM - Armenia 3
CI - Costa d'Avorio 3
ET - Etiopia 3
HR - Croazia 3
KW - Kuwait 3
NI - Nicaragua 3
PS - Palestinian Territory 3
AZ - Azerbaigian 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
JO - Giordania 2
KH - Cambogia 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
RS - Serbia 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
RW - Ruanda 1
SC - Seychelles 1
Totale 49.978
Città #
Cagliari 40.167
Uta 2.401
Dallas 592
Ashburn 404
Singapore 364
Boardman 164
Chandler 146
Beijing 128
Fairfield 125
Los Angeles 118
Nyköping 106
Hefei 105
New York 100
Hong Kong 73
Munich 72
The Dalles 72
Santa Clara 69
Shanghai 67
Ho Chi Minh City 60
Rome 59
Seoul 57
Houston 54
Seattle 54
São Paulo 53
Wilmington 45
Boston 41
Hanoi 39
Montreal 38
Woodbridge 38
Helsinki 37
Tokyo 37
Buffalo 33
Cambridge 33
Casablanca 30
Frankfurt am Main 30
Melbourne 30
Redondo Beach 28
Milan 24
Johannesburg 23
Turku 23
Brooklyn 21
Denver 21
Chicago 20
Lappeenranta 20
Nuremberg 20
Orem 20
San Diego 20
Warsaw 20
Poplar 19
Ankara 18
Dong Ket 18
Ann Arbor 17
Phoenix 17
Stockholm 17
London 16
Selargius 16
Sydney 16
Vienna 16
Amsterdam 15
Atlanta 15
Toronto 15
Dublin 14
Chennai 13
Council Bluffs 13
Mexico City 13
Sassari 12
City of London 11
Naples 11
Washington 11
Curitiba 10
Iași 10
Jacksonville 10
Manchester 10
Nanjing 10
San Francisco 10
Shenzhen 10
Dearborn 9
Düsseldorf 9
Redwood City 9
Rio de Janeiro 9
Belo Horizonte 8
Boydton 8
Calgary 8
Nairobi 8
Richmond 8
Tampa 8
Torre Del Greco 8
Cairo 7
Dhaka 7
Goiânia 7
Istanbul 7
Jeddah 7
Norwalk 7
Padova 7
Tashkent 7
Tehran 7
Wan Chai 7
Brasília 6
Campinas 6
Charlotte 6
Totale 46.864
Nome #
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.469
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 2.952
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.831
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.646
The elderly and the city: Lack of knowledge on violence perception and consequences on daily life 2.193
Mental health in transgender individuals: a systematic review 1.775
How promising is neuroactive steroid drug discovery? 1.689
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications 1.637
Pharmacological management of depression in patients with multiple sclerosis 1.563
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review 1.544
Current pharmacotherapeutic approaches for dysthymic disorder and persistent depressive disorder 1.524
Precision psychiatry for suicide prevention 1.484
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.212
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.212
Expression of l1 cell adhesion molecule (l1cam) in extracellular vesicles in the human spinal cord during development 1.110
The role of gut microbiota in the high-risk construct of severe mental disorders: A mini review 1.010
A genome-wide association study of antidepressant-induced mania 928
Strong ACE-2 expression in the choroidal vessels: do high choroid plexuses serve as a gateway for SARS-CoV-2 infection on the human brain? 903
Depression in Diabetic Patients: What Is the Link With Eating Disorders? Results of a Study in a Representative Sample of Patients With Type 1 Diabetes 860
Leukocytosis associated with clozapine treatment: A case series and systematic review of the literature 774
Identifying Neurobiological Markers in Obsessive–Compulsive Disorder: A Study Protocol for a Cross-Sectional Study in Subgroups of Differing Phenotype 757
Involvement of gut microbiota in schizophrenia and treatment resistance to antipsychotics 733
Cost–utility analysis of pharmacogenetic testing based on CYP2C19 or CYP2D6 in major depressive disorder: assessing the drivers of different cost-effectiveness levels from an Italian societal perspective 723
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders 719
Investigation of Genetic Variants Associated with Tryptophan Metabolite Levels via Serotonin and Kynurenine Pathways in Patients with Bipolar Disorder 713
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis 669
Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study 662
A review and meta-analysis of gene expression profiles in suicide 618
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review 613
An integrated precision medicine approach in major depressive disorder: a study protocol to create a new algorithm for the prediction of treatment response 600
Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence 598
Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies 594
Gut Microbiota Research in Bipolar Disorder and Possible Implications for Precision Psychiatry: A Systematic Review 593
Dissecting the genetic overlap between severe mental disorders and markers of cellular aging: Identification of pleiotropic genes and druggable targets 583
Surviving to acute myocardial infarction: The role of psychological factors and alexithymia in delayed time to searching care: A systematic review 546
Impulsivity, aggressivity and mood disorders: a narrative review 526
Food and Alcohol Disturbance in High School Adolescents: Prevalence, Characteristics and Association with Problem Drinking and Eating Disorders 501
Melatonin MT1 receptors as a target for the psychopharmacology of bipolar disorder: A translational study 456
Symptomatic remission and recovery in major psychosis: Is there a role for BDNF? A secondary analysis of the LABSP cohort data 423
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 408
A Pilot Interaction Analysis of Gut Microbiota and Peripheral Markers of Aging in Severe Psychiatric Disorders: A Role for Lachnoclostridium? 362
A Secondary Analysis of the Complex Interplay between Psychopathology, Cognitive Functions, Brain Derived Neurotrophic Factor Levels, and Suicide in Psychotic Disorders: Data from a 2-Year Longitudinal Study 320
Self-harm and suicidality among LGBTIQ people: a systematic review and meta-analysis 316
Mental health for LGBTQI people: a policies' review 275
The Role of Copper Overload in Modulating Neuropsychiatric Symptoms 253
Lithium and its effects: does dose matter? 241
Do Long-Acting Injectable Antipsychotics Influence Serum Levels of Brain-Derived Neurotrophic Factor in People with Schizophrenia and Schizoaffective Disorder? 210
Leukocyte Telomere Length and Mitochondrial DNA Copy Number in Treatment-Resistant Depression and Response to Electroconvulsive Therapy: A Pilot Longitudinal Study 203
Sex differences in shared genetic determinants between severe mental disorders and metabolic traits 195
Lower Plasma Levels of Selective VGF (Non-Acronymic) Peptides in Bipolar Disorder: Comparative Analysis Reveals Distinct Patterns across Mood Disorders and Healthy Controls 182
Identifying molecular signatures of post-traumatic stress disorder vulnerability and progression in a longitudinal study: a study protocol 166
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 164
Barriers in care pathways and unmet mental health needs in LGBTIQ + communities 155
Focus on Suicidal Behaviours - The experience of the11th EPA Summer School 140
Experience of childhood adversity and maladaptive personality traits: Magnitude and specificity of the association in a clinical sample of adult outpatients 133
Association of pharmacodynamic genes with treatment outcomes in major depressive disorder: results from a Sardinian cohort 125
Association Between Current Suicidal Ideation and Personality Traits: Analysis of the Personality Inventory for DSM-5 in a Community Mental Health Sample 121
Mitochondrial DNA copy number is significantly increased in bipolar disorder patients and is correlated with long-term lithium treatment 119
Impact of repetitive transcranial magnetic stimulation on clinical and cognitive outcomes, and brain-derived neurotrophic factor levels in treatment-resistant depression 112
A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 e CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder 105
The Importance of Antipsychotic Treatment in Severe Mental Disorders 105
Telomere length and mitochondrial DNA copy number in association with trauma-focused psychotherapy efficacy 96
Pharmacogenomics and response to lithium in bipolar disorder 95
The role of affective temperaments in self-care and medication adherence among individuals with bipolar disorder: a moderation analysis 93
The clock is ticking on schizophrenia: a study protocol for a translational study integrating phenotypic, genomic, microbiome and biomolecular data to overcome disability 86
A stratified treatment algorithm in psychiatry: a program on stratified pharmacogenomics in severe mental illness (Psych-STRATA): concept, objectives and methodologies of a multidisciplinary project funded by Horizon Europe 85
Genomics and pharmacogenomics of cluster headache: Implications for personalized management? A systematic review 84
Refining Criteria for a Neurodevelopmental Subphenotype of Bipolar Disorders: A FondaMental Advanced Centers of Expertise for Bipolar Disorders Study 77
Biomarkers of stress resilience: A review 76
Psychiatric assessment in image-based sexual abuse case: a case report on imputability in personality disorder with narcissistic traits 75
Corrigendum to “A naturalistic retrospective evaluation of the utility of pharmacogenetic testing based on CYP2D6 and CYP2C19 profiling in antidepressants treatment in a cohort of patients with major depressive disorder” [Progress in Neuropsychopharmacology and Biological Psychiatry (2025) 111292] (Progress in Neuropsychopharmacology & Biological Psychiatry (2025) 137, (S0278584625000466), (10.1016/j.pnpbp.2025.111292)) 65
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN) 64
Identification of peripheral biomarkers through metabolomic analysis in patients with bipolar disorder treated with mood stabilizers: an exploratory study 30
Totale 50.279
Categoria #
all - tutte 71.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.380 0 0 0 0 0 1.092 428 653 345 729 706 427
2021/20223.395 381 197 144 238 326 191 147 121 307 378 473 492
2022/20235.633 250 608 683 461 474 733 304 374 376 368 583 419
2023/20246.950 298 198 216 351 565 1.040 982 563 400 521 783 1.033
2024/202518.068 3.896 4.907 2.254 2.184 1.101 1.472 1.057 139 243 211 210 394
2025/20264.714 679 521 1.105 920 966 523 0 0 0 0 0 0
Totale 50.279